Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that drain blood from the brain and spinal cord over a prolonged period.
Study reveals important mechanism that allows immune cells to attack myelin in MS
A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s advocacy work to increase funding for MSSNs
Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between the two organisations
Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring people with MS
MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants
New Support Line will provide information and support, as well as jobs for people living with MS
The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be prescribed for adults with early primary progressive MS
Scientists have been using a large database to develop algorithms to predict individual responses to a particular therapy before starting it.
A new small study has discovered molecules in the blood that are specific to people with MS, and can distinguish between relapsing remitting and progressive MS.
Researchers have been trialling low current electric brain stimulation as a way to help manage MS related fatigue.
Anti-histamine drug clemastine may boost myelin repair in MS